本文へ移動
cccskills
無料GitHub で公開

es-check-hormone-levels-target-range

Determines if current hormone levels are within target range for affirmed gender (e.g., testosterone 400-700 ng/dL for transgender males, estradiol 100-200 pg/mL for transgender females). Triggers include patient on hormone therapy and time for level check.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.3 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Check if hormone levels are in target range for affirmed gender

STEP 1 — Gather Information

Collect patient's affirmed gender, current hormone therapy regimen (type, dose, frequency), timing of last dose, and most recent serum testosterone (for transgender males) or estradiol (for transgender females) level.

STEP 2 — Rule In / Rule Out

Is the patient currently receiving gender-affirming hormone therapy? If yes, proceed to step 3; if no, hormone level check is not indicated for this purpose.

STEP 3 — Classify or Stratify

Compare measured hormone level to target range: for transgender males, target testosterone 400–700 ng/dL; for transgender females, target estradiol 100–200 pg/mL. Also verify suppression of endogenous sex steroids (testosterone <50 ng/dL in transgender females; estradiol <50 pg/mL in transgender males) if clinically relevant.

STEP 4 — Decide

If hormone level is within target range, continue current regimen. If below target, consider dose increase after assessing adherence and timing. If above target, evaluate for adverse effects and consider dose reduction or dosing interval adjustment.

Clinical Guardrails / Mimics / Pitfalls

Do not adjust dose based on a single out-of-range level without confirming timing relative to dose and assay reliability. Avoid supraphysiologic dosing to reduce thrombotic or erythrocytosis risk. Ensure assays are ultrasensitive and performed at appropriate trough/peak times as per formulation.

Concrete Clinical Example

A transgender male receives testosterone enanthate 100 mg IM weekly. Laboratory shows testosterone 350 ng/dL (below target 400–700 ng/dL). After confirming adherence and proper trough sampling, dose is increased to 125 mg weekly.

Source: Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2017, DOI:10.1210/jc.2017-01658

TODO: consider adding scripts/calc.py for the es-check-hormone-levels-target-range calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する